{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:33:48Z","timestamp":1771925628068,"version":"3.50.1"},"reference-count":117,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.07.030","type":"journal-article","created":{"date-parts":[[2007,8,7]],"date-time":"2007-08-07T12:33:30Z","timestamp":1186490010000},"page":"7017-7030","source":"Crossref","is-referenced-by-count":39,"title":["Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseases"],"prefix":"10.1016","volume":"25","author":[{"given":"Lynn W.","family":"Kitchen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.07.030_bib1","series-title":"National Institute of Allergy and Infectious Diseases: intramural contributions, 1887\u20131987","first-page":"61","article-title":"The regulation of biologic products, 1902\u20131972","author":"Pittman","year":"1987"},{"key":"10.1016\/j.vaccine.2007.07.030_bib2","series-title":"Science and the regulation of biological products: from a rich history to a challenging future","author":"Center for Biologics Evaluation and Research","year":"2002"},{"key":"10.1016\/j.vaccine.2007.07.030_bib3","series-title":"The great influenza: the epic story of the deadliest plague in history","author":"Barry","year":"2004"},{"key":"10.1016\/j.vaccine.2007.07.030_bib4","series-title":"Epidemic and peace, 1918","author":"Crosby","year":"1976"},{"key":"10.1016\/j.vaccine.2007.07.030_bib5","series-title":"The Armed Forces Epidemiological Board: the histories of the commissions","year":"1994"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI101633","article-title":"Protective effect of vaccination against induced influenza A","volume":"24","author":"Francis","year":"1945","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI101634","article-title":"Protective effect of vaccination against induced influenza B","volume":"24","author":"Salk","year":"1945","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/oxfordjournals.aje.a119025","article-title":"A clinical, epidemiological and immunological evaluation of vaccination against epidemic influenza","volume":"42","author":"Salk","year":"1945","journal-title":"Am J Epidemiol"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.07.030_bib9","first-page":"725","article-title":"Vaccination against influenza","volume":"8","author":"Francis","year":"1953","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.030_bib10","first-page":"198","article-title":"The role of military medical services in future epidemic influenza","volume":"83","author":"McNinch","year":"1961","journal-title":"Am Rev Respir Dis"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib11","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1093\/infdis\/136.Supplement_3.S356","article-title":"Swine influenza A at Fort Dix, New Jersey (January\u2013February 1976). I. Case finding and clinical study of cases","volume":"136","author":"Gaydos","year":"1977","journal-title":"J Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib12","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1093\/infdis\/136.Supplement_3.S363","article-title":"Swine influenza A at Fort Dix, New Jersey (January\u2013February 1976). II. Transmission and morbidity in units with cases","volume":"136","author":"Gaydos","year":"1977","journal-title":"J Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib13","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1093\/infdis\/136.Supplement_3.S369","article-title":"Swine influenza A at Fort Dix, New Jersey (January\u2013February 1976). III. Extent of spread and duration of the outbreak","volume":"136","author":"Hodder","year":"1977","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.030_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.07.030_bib15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/oxfordjournals.aje.a115974","article-title":"Guillain\u2013Barre syndrome and influenza vaccination in the US Army, 1980\u20131988","volume":"133","author":"Roscelli","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.248.6.698","article-title":"Guillain\u2013Barre syndrome in the United States, 1979\u20131980 and 1980\u20131981. Lack of an association with influenza vaccination","volume":"248","author":"Kaplan","year":"1982","journal-title":"JAMA"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7205\/MILMED.170.4S.66","article-title":"History of U.S. military contributions to the study of respiratory infections","volume":"170","author":"Ottolini","year":"2005","journal-title":"Mil Med"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/infdis\/156.4.649","article-title":"Influenza at Lowry Air Force Base in Denver, 1982\u20131986","volume":"156","author":"Meiklejohn","year":"1987","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.030_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/148.5.775","article-title":"Viral respiratory disease at Lowry Air Force Base in Denver, 1952\u20131982","volume":"148","author":"Meiklejohn","year":"1983","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.030_bib20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/infdis\/138.5.618","article-title":"Antigenic drift and efficacy of influenza virus vaccines, 1976\u20131977","volume":"138","author":"Meiklejohn","year":"1978","journal-title":"J Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib21","doi-asserted-by":"crossref","first-page":"S456","DOI":"10.1093\/infdis\/136.Supplement_3.S456","article-title":"Antibody response of young adults to experimental influenza A\/New Jersey\/76 virus vaccines","volume":"136","author":"Meiklejohn","year":"1977","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/clinids\/1.6.946","article-title":"Comparison of several wild-type influenza viruses in the ferret tracheal organ culture system","volume":"1","author":"Hoke","year":"1979","journal-title":"Rev Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/infdis\/147.6.1099","article-title":"Efficacy of single-dose influenza in Air Force recruits","volume":"147","author":"Gremillion","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.030_bib24","series-title":"ACP medicine","article-title":"Measles, mumps, rubella, parvovirus, and poxvirus","author":"Hirsch","year":"2006"},{"key":"10.1016\/j.vaccine.2007.07.030_bib25","series-title":"ImmunoFacts: vaccines and immunologic drugs","author":"Grabenstein","year":"2005"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7205\/MILMED.170.4S.3","article-title":"History of U.S. military contributions to the study of vaccines against infectious diseases","volume":"170","author":"Artenstein","year":"2005","journal-title":"Mil Med"},{"issue":"11","key":"10.1016\/j.vaccine.2007.07.030_bib27","first-page":"279","article-title":"Elimination of rubella and congenital rubella syndrome, United States, 1969\u20132004","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2007.07.030_bib28","series-title":"Presented at the International Conference on Emerging Infectious Diseases","article-title":"Where's adeno? A search for the occurrence of adenovirus-associated respiratory disease outside of the U.S. military","author":"Sivan","year":"2006"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3181\/00379727-85-20825","article-title":"Recovery of new agent from patients with acute respiratory illness","volume":"85","author":"Hilleman","year":"1954","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib30","first-page":"29","article-title":"Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations","volume":"62","author":"Hilleman","year":"1955","journal-title":"Am J Hyg"},{"issue":"6 Pt 2","key":"10.1016\/j.vaccine.2007.07.030_bib31","first-page":"34","article-title":"Appraisal of studies in the light of subsequent knowledge of etiology of the acute viral respiratory diseases","volume":"97","author":"Anonymous","year":"1968","journal-title":"Am Rev Respir Dis"},{"issue":"6 Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib32","first-page":"1","article-title":"Epidemiology of acute, respiratory disease in military recruits","volume":"97","author":"Dingle","year":"1968","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2007.07.030_bib33","series-title":"Vaccines","first-page":"863","article-title":"Adenovirus vaccines","author":"Gaydos","year":"2004"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jama.195.6.445","article-title":"Immunization by selective infections with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers","volume":"195","author":"Chanock","year":"1966","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.195.6.453","article-title":"Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. Specific protective effect against epidemic disease","volume":"195","author":"Edmondson","year":"1966","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.030_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/infdis\/124.2.148","article-title":"Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccines in humans","volume":"124","author":"Top","year":"1971","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.030_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/infdis\/124.2.155","article-title":"Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7","volume":"124","author":"Top","year":"1971","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.030_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3201\/eid0503.990308","article-title":"Respiratory diseases among U.S. military personnel: countering emerging threats","volume":"5","author":"Gray","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.030_bib39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/313999","article-title":"Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics","volume":"31","author":"Gray","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.030_bib40","series-title":"ACP Medicine","article-title":"Infections due to Neisseria","author":"Marrazzo","year":"2006"},{"issue":"845","key":"10.1016\/j.vaccine.2007.07.030_bib41","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.161.3845.1019","article-title":"Sulfadiazine-resistant group A Neisseria meningitidis","volume":"161","author":"Alexander","year":"1968","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib42","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib44","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","article-title":"Human immunity to the meningococcus. III. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib45","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib46","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1084\/jem.129.6.1385","article-title":"Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2007.07.030_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197002192820803","article-title":"Prevention of meningococcal disease by group C polysaccharide vaccine","volume":"282","author":"Artenstein","year":"1970","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.030_bib48","first-page":"279","article-title":"Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969\u20131970","volume":"45","author":"Gold","year":"1971","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.030_bib49","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/IAI.34.3.725-732.1981","article-title":"Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults","volume":"34","author":"Griffiss","year":"1981","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/IAI.37.1.205-208.1982","article-title":"Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines","volume":"37","author":"Griffiss","year":"1982","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-1157(82)80010-3","article-title":"Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation","volume":"10","author":"Armand","year":"1982","journal-title":"J Biol Stand"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3181\/00379727-169-41306","article-title":"Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135","volume":"169","author":"Hankins","year":"1982","journal-title":"Proc Soc Exp Biol Med"},{"issue":"11","key":"10.1016\/j.vaccine.2007.07.030_bib53","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1086\/344273","article-title":"Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964\u20131998","volume":"35","author":"Brundage","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.030_bib54","first-page":"5","article-title":"Evolution of meningococcal disease epidemiology in the U.S. Army","volume":"vol. 1","author":"Brundage","year":"1987"},{"key":"10.1016\/j.vaccine.2007.07.030_bib55","unstructured":"U.S. Food and Drug Administration. Meningococcal polysaccharide (serogroups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (Menactra) [product approval information, licensing action]. Available at: http:\/\/www.fda.gov\/cber\/products\/mpdtave011405.htm (accessed October 6, 2006)."},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.030_bib56","first-page":"364","article-title":"Meningococcal disease: challenges in prevention and management","volume":"17","author":"Leake","year":"2000","journal-title":"Infect Med"},{"issue":"9","key":"10.1016\/j.vaccine.2007.07.030_bib57","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.07.030_bib58","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0264-410X(99)00216-9","article-title":"Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers","volume":"18","author":"Drabick","year":"1999","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.07.030_bib59","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/IAI.73.7.4070-4080.2005","article-title":"Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination","volume":"73","author":"Fisseha","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.030_bib60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/oxfordjournals.aje.a118911","article-title":"Jaundice in Army personnel in the western region of the United States and its relation to vaccination against yellow fever. Part I","volume":"39","author":"Sawyer","year":"1944","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/oxfordjournals.aje.a118977","article-title":"Jaundice in Army personnel in the western region of the United States and its relation to vaccination against yellow fever. Parts II\u2013IV","volume":"40","author":"Sawyer","year":"1944","journal-title":"Am J Epidemiol"},{"issue":"244","key":"10.1016\/j.vaccine.2007.07.030_bib62","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(00)42371-8","article-title":"Jaundice following yellow fever immunisation: transmission by intranasal instillation","volume":"1","author":"Findlay","year":"1943","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.030_bib63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2307\/4584414","article-title":"Aqueous-base yellow fever vaccine","volume":"58","author":"Hargett","year":"1943","journal-title":"Pub Health Rep"},{"key":"10.1016\/j.vaccine.2007.07.030_bib64","series-title":"Hepatitis B: the hunt for a killer virus","author":"Blumberg","year":"2002"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7205\/MILMED.170.4S.71","article-title":"History of U.S. military contributions to the study of viral hepatitis","volume":"170","author":"Dooley","year":"2005","journal-title":"Mil Med"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.030_bib66","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/hep.1840010502","article-title":"A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report","volume":"1","author":"Szmuness","year":"1981","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib67","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4049\/jimmunol.109.4.842","article-title":"Detection of additional antigenic determinants of hepatitis B antigen","volume":"109","author":"Bancroft","year":"1972","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/infdis\/135.1.79","article-title":"Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen","volume":"135","author":"Bancroft","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.030_bib69","series-title":"Bullets and Bacilli: the Spanish-American War and military medicine","author":"Cirillo","year":"2004"},{"key":"10.1016\/j.vaccine.2007.07.030_bib70","series-title":"Civil war medicine: challenges and triumphs","author":"Bollet","year":"2002"},{"key":"10.1016\/j.vaccine.2007.07.030_bib71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00000441-191312000-00004","article-title":"Antityphoid inoculation","volume":"146","author":"Russell","year":"1913","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.030_bib72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1353\/bhm.2000.0073","article-title":"\u201cStraight back to barbarism\u201d: antityphoid inoculation and the Great War, 1914","volume":"74","author":"Hardy","year":"2000","journal-title":"Bull Hist Med"},{"key":"10.1016\/j.vaccine.2007.07.030_bib73","series-title":"The Medical Department of the United States Army in the World War, vol. IX: communicable and other diseases","author":"U.S. Army Surgeon General's Office","year":"1928"},{"key":"10.1016\/j.vaccine.2007.07.030_bib74","series-title":"Immunization to typhoid fever: results obtained in the prevention of typhoid fever in the United States Army, United States Navy, and Civilian Conservation Corps, by the use of vaccines","author":"U.S. Army Medical School","year":"1941"},{"issue":"8541","key":"10.1016\/j.vaccine.2007.07.030_bib75","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation","volume":"1","author":"Levine","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0264-410X(90)90183-M","article-title":"Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial","volume":"8","author":"Black","year":"1990","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib77","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","article-title":"Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area","volume":"159","author":"Ferreccio","year":"1989","journal-title":"J Infect Dis"},{"issue":"8774","key":"10.1016\/j.vaccine.2007.07.030_bib78","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0140-6736(91)91910-M","article-title":"Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine","volume":"338","author":"Simanjuntak","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.030_bib79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7326\/0003-4819-29-1-131","article-title":"Preliminary report on the beneficial effect of chloromycetin in the treatment of typhoid fever","volume":"29","author":"Woodward","year":"1948","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib80","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/clinids\/21.4.1045","article-title":"Efficacy of azithromycin for typhoid fever","volume":"21","author":"Tribble","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2007.07.030_bib81","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/BF01992163","article-title":"Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever","volume":"12","author":"Wallace","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.030_bib82","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/317450","article-title":"Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children","volume":"31","author":"Frenck","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib83","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.43.6.1441","article-title":"Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance","volume":"43","author":"Girgis","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.030_bib84","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJM198401123100203","article-title":"Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone","volume":"310","author":"Hoffman","year":"1984","journal-title":"N Engl J Med"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib85","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7205\/MILMED.170.4S.30","article-title":"History of U.S. military contributions to the study of diarrheal diseases","volume":"170","author":"Lim","year":"2005","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2007.07.030_bib86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidemiol Rev"},{"issue":"Suppl 9","key":"10.1016\/j.vaccine.2007.07.030_bib87","first-page":"126","article-title":"The ecology of Japanese encephalitis virus in Japan","volume":"16","author":"Buescher","year":"1959","journal-title":"An Inst Med Trop (Lisb)"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.030_bib88","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4269\/ajtmh.1999.61.288","article-title":"Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimens","volume":"61","author":"Defraites","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2007.07.030_bib89","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7205\/MILMED.170.4S.92","article-title":"History of U.S. military contributions to the study of viral encephalitis","volume":"170","author":"Hoke","year":"2005","journal-title":"Mil Med"},{"issue":"10","key":"10.1016\/j.vaccine.2007.07.030_bib90","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"issue":"8695","key":"10.1016\/j.vaccine.2007.07.030_bib91","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/0140-6736(90)91036-A","article-title":"Further experience with Japanese encephalitis vaccine","volume":"335","author":"Sanchez","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.030_bib92","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/JCM.15.3.353-361.1982","article-title":"Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay","volume":"15","author":"Burke","year":"1982","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib93","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/infdis\/171.4.1074","article-title":"Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series","volume":"171","author":"Gambel","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.07.030_bib94","series-title":"Civil war medicine: challenges and triumphs","author":"Bollet","year":"2002"},{"key":"10.1016\/j.vaccine.2007.07.030_bib95","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.1945.02860320004002","article-title":"The use of human immune serum globulin (gamma globulin) in infectious (epidemic) hepatitis in the Mediterranean theater of operations. I. Studies on prophylaxis in two epidemics of infectious hepatitis","volume":"128","author":"Gellis","year":"1945","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.030_bib96","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archinte.128.5.723","article-title":"Prophylactic gamma globulin for prevention of endemic hepatitis. Effects of US gamma globulin upon the incidence of viral hepatitis and other infectious diseases in US soldiers abroad","volume":"128","author":"Anonymous","year":"1971","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib97","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/156.1.56","article-title":"Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin","volume":"156","author":"Conrad","year":"1987","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib98","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/infdis\/153.4.749","article-title":"Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures","volume":"153","author":"Binn","year":"1986","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.030_bib99","doi-asserted-by":"crossref","first-page":"470","DOI":"10.7326\/0003-4819-114-6-470","article-title":"Immunogenicity of an inactivated hepatitis A vaccine","volume":"114","author":"Sjogren","year":"1991","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.07.030_bib100","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/0264-410X(92)90550-4","article-title":"Hepatitis A in the US Army: epidemiology and vaccine development","volume":"10","author":"Hoke","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.030_bib101","series-title":"Presented at the American Society of Tropical Medicine and Hygiene 54th annual meeting","article-title":"Protection against hepatitis E by a recombinant vaccine","author":"Shrestha","year":"2005"},{"key":"10.1016\/j.vaccine.2007.07.030_bib102","series-title":"Rocky mountain spotted fever: history of a twentieth-century disease","author":"Harden","year":"1990"},{"key":"10.1016\/j.vaccine.2007.07.030_bib103","series-title":"Preventive medicine in World War II, vol. III: personal health measures and immunization","author":"Medical Department, U.S. Army","year":"1955"},{"issue":"8","key":"10.1016\/j.vaccine.2007.07.030_bib104","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1128\/IAI.73.8.5039-5047.2005","article-title":"Scrub typhus vaccine candidate Kp r56 induces humoral and cellular immune responses in cynomolgus monkeys","volume":"73","author":"Chattopadhyay","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.07.030_bib105","unstructured":"Sabin Vaccine Institute. Human Hookworm Vaccine Initiative (HHVI) overview. Available at: http:\/\/www.sabin.org\/hookworm.htm (accessed October 11, 2006)."},{"key":"10.1016\/j.vaccine.2007.07.030_bib106","series-title":"Bugs in armor: a tale of malaria and soldiering","author":"Bwire","year":"1999"},{"key":"10.1016\/j.vaccine.2007.07.030_bib107","unstructured":"Malaria outbreak among members of JTF Liberia: consensus conference report [October 9, 2003]. Available at: http:\/\/www-nehc.med.navy.mil\/downloads\/prevmed\/JTFMalaria.pdf (accessed October 11, 2006)."},{"issue":"9502","key":"10.1016\/j.vaccine.2007.07.030_bib108","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial","volume":"366","author":"Alonso","year":"2005","journal-title":"Lancet"},{"issue":"17\u20138","key":"10.1016\/j.vaccine.2007.07.030_bib109","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.vaccine.2005.01.142","article-title":"Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research","volume":"23","author":"Heppner","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.030_bib110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14728214.10.3.489","article-title":"Malaria vaccines in development","volume":"10","author":"Ballou","year":"2005","journal-title":"Expert Opin Emerg Drugs"},{"issue":"9","key":"10.1016\/j.vaccine.2007.07.030_bib111","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1086\/383418","article-title":"Commentary: Ashburn PM, Craig CF. Experimental investigations regarding the etiology of dengue [J Infect Dis 1907;4:440\u201375]","volume":"189","author":"Gubler","year":"2004","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2007.07.030_bib112","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1086\/503372","article-title":"Protection of rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination","volume":"193","author":"Sun","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib113","first-page":"9","article-title":"Military importance of diarrhea: lessons from the Middle East","volume":"21","author":"Sanders","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"issue":"18","key":"10.1016\/j.vaccine.2007.07.030_bib114","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.75.18.8469-8477.2001","article-title":"DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys","volume":"75","author":"Hooper","year":"2001","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib115","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/422258","article-title":"Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults","volume":"190","author":"Nitayaphan","year":"2004","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.030_bib116","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/505979","article-title":"HIV vaccines: new frontiers in vaccine development","volume":"43","author":"Duerr","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.030_bib117","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/504873","article-title":"Role of US military research programs in the development of US Food and Drug Administration-approved antimalarial drugs","volume":"43","author":"Kitchen","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07008353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07008353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T18:20:03Z","timestamp":1684002003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07008353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":117,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07008353"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}